| mRNA |
TAE684 |
CCLE |
pan-cancer |
AAC |
0.0049 |
0.9 |
| mRNA |
nintedanib |
CTRPv2 |
pan-cancer |
AAC |
-0.0039 |
0.9 |
| mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0037 |
0.9 |
| mRNA |
myriocin |
CTRPv2 |
pan-cancer |
AAC |
0.0084 |
0.9 |
| mRNA |
Erlotinib |
UHNBreast |
pan-cancer |
AAC |
0.028 |
0.9 |
| mRNA |
CAL-101 |
CTRPv2 |
pan-cancer |
AAC |
0.0037 |
0.9 |
| mRNA |
elocalcitol |
CTRPv2 |
pan-cancer |
AAC |
-0.0034 |
0.9 |
| mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0035 |
0.9 |
| mRNA |
cediranib |
CTRPv2 |
pan-cancer |
AAC |
0.0052 |
0.9 |
| mRNA |
Genentech Cpd 10 |
GDSC1000 |
pan-cancer |
AAC |
-0.003 |
0.9 |